Projects per year
Fingerprint
Dive into the research topics where Krishnendu Pal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Overriding Radiation Therapy Resistance and Enhancing the Abscopal Effect in Renal Cancer
Pal, K. (PI)
Congressionally Directed Medical Research Programs
1/1/20 → …
Project: Research project
-
Restoring immune-vascular axis integrity to alleviate acute lung injury in sepsis
Pal, K. (PI)
National Heart, Lung, and Blood Institute
9/1/22 → 8/31/24
Project: Research project
-
Dual Targeting of Syndecan-1 and Glucose Transporter-1 With a Novel Lipid-Based Delivery System Enhances Therapeutic Efficacy and Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma
Rachamala, H. K., Nakka, N. M. R., Angom, R. S., Bhattacharya, S., Pal, K. & Mukhopadhyay, D., Jan 2025, In: Gastroenterology. 168, 1, p. 160-163.e4Research output: Contribution to journal › Short survey › peer-review
Open Access -
Dual drug-loaded tumor-targeted polymeric nanoparticles for enhancing therapeutic response in pancreatic ductal adenocarcinoma
Nakka, N. M. R., Rachamala, H. K., Angom, R. S., Indla, N. R., Dutta, S. K., Wang, E., Bhattacharya, S., Sesha Sainath, A. V., Babiker, H., Pal, K. & Mukhopadhyay, D., Oct 2024, In: Materials Today Bio. 28, 101199.Research output: Contribution to journal › Article › peer-review
Open Access -
Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe
Rachamala, H. K., Madamsetty, V. S., Angom, R. S., Nakka, N. M., Dutta, S. K., Wang, E., Mukhopadhyay, D. & Pal, K., Dec 2024, In: Journal of Experimental and Clinical Cancer Research. 43, 1, 159.Research output: Contribution to journal › Article › peer-review
Open Access -
Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma
Pal, K., Hussain, T., Xie, H., Li, S., Yang, P., Mansfield, A., Lou, Y., Chowdhury, S. & Mukhopadhyay, D., Aug 22 2022, In: Frontiers in Oncology. 12, 959500.Research output: Contribution to journal › Article › peer-review
Open Access -
Vascular Endothelial Growth Factor as an Immediate-Early Activator of Ultraviolet-Induced Skin Injury
Hartono, S. P., Bedell, V. M., Alam, S. K., O'Gorman, M., Serres, M. K., Hall, S. R., Pal, K., Kudgus, R. A., Mukherjee, P., Seelig, D. M., Meves, A., Mukhopadhyay, D., Ekker, S. C. & Hoeppner, L. H., Jan 2022, In: Mayo Clinic proceedings. 97, 1, p. 154-164 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access